期刊文献+
共找到14篇文章
< 1 >
每页显示 20 50 100
射频自凝刀靶点治疗子宫肌瘤的急性临床病理学试验 被引量:60
1
作者 罗新 宋雯霞 +2 位作者 洪莉 吴秀枝 常明伟 《武汉大学学报(医学版)》 CAS 2003年第3期277-280,T002,共5页
目的 :通过观察被射频消融热毁损肌瘤组织的病理形态学改变和雌激素受体 (ER)、孕激素受体 (PR)表达的变化 ,循证射频自凝刀靶点治疗子宫肌瘤微创技术的基本原理。方法 :对需行子宫全切的 30例多发性子宫肌瘤患者 ,分别采用 0 .5cm、1.... 目的 :通过观察被射频消融热毁损肌瘤组织的病理形态学改变和雌激素受体 (ER)、孕激素受体 (PR)表达的变化 ,循证射频自凝刀靶点治疗子宫肌瘤微创技术的基本原理。方法 :对需行子宫全切的 30例多发性子宫肌瘤患者 ,分别采用 0 .5cm、1.2cm长的射频自凝刀头对其行射频消融 ,其中 2 8例消融治疗后立即切除子宫 (急性试验组 ) ,征得同意 2例于消融治疗 3d后切除子宫 (慢性试验组 )。试验组从消融灶中心 (A组 )、边缘 (B组 )、边缘外1cm(C组 )、边缘外 2cm(D组 )处取材 ,HE染色下观察病理变化 ,免疫组化检测ER、PR水平 ;对照组取材选同一子宫上未做射频消融的肌瘤组织。结果 :射频消融治疗后 ,消融灶中心肌瘤组织呈凝固性坏死 ,ER、PR无表达 ;消融灶边缘肌瘤细胞变性 ,ER、PR表达减少 (P <0 .0 5 ) ;消融灶边缘外 1cm ,肌瘤细胞无变性、坏死 ,但ER、PR表达仍低于对照组 (P <0 .0 5 ) ;消融灶边缘外 2cm ,ER、PR与对照组相比差异无显著性 (P >0 .0 5 )。结论 :射频消融微创技术使肌瘤组织凝固性坏死 ,ER、PR的表达消失或减低 ,从而达到治疗子宫肌瘤的目的 ,这可能是射频消融治疗子宫肌瘤的主要机制和基本原理。 展开更多
关键词 射频自凝刀靶点 治疗 子宫肌瘤 急性临床病理试验
下载PDF
抗胃癌生物导向药物病理组织学试验
2
作者 余琼 张元曦 +1 位作者 张琳 赵宁 《黑龙江医药》 CAS 1996年第4期181-182,共2页
抗胃癌生物导向药物(IgY-RicinA)是一种新型抗胃癌药物,为进一步给临床使用提供依据,我们对其进行了病理组织学试验研究,现报告如下:试验材料动物为 wistar 大鼠,体重110—150g。
关键词 胃癌 IgY-RicinA 抗癌药 病理组织学试验
下载PDF
醋酸试验阴道镜病理检查联合应用筛查宫颈病变临床应用价值的的初步探索
3
作者 黄建红 王兰 +1 位作者 辛菊英 彭启凤 《中外医学研究》 2009年第8期53-54,共2页
目的探讨醋酸试验阴道镜病理检查联合应用筛查宫颈病变临床应用价值。方法随机选择到笔者所在医院妇科门诊就诊,有阴道镜检查指征的妇女300例,随机分为干预组、对照组。干预组:予醋酸试验阴道镜病理检查联合应用筛查宫颈病变;对照... 目的探讨醋酸试验阴道镜病理检查联合应用筛查宫颈病变临床应用价值。方法随机选择到笔者所在医院妇科门诊就诊,有阴道镜检查指征的妇女300例,随机分为干预组、对照组。干预组:予醋酸试验阴道镜病理检查联合应用筛查宫颈病变;对照组:醋酸试验、碘试验阴道镜病理检查联合应用筛查宫颈病变。结果醋白上皮持续时间大于6min助于提高宫颈上皮内瘤样病变CIN的准确性;干预组:灵敏度97.61%、特异度75.94%、误诊率24.05%、漏诊率2.38%、粗符合率83.47%、校正符合率61.16%。对照组:灵敏度89.47%、特异度75%、误诊率25%、漏诊率10.52%、粗符合率77.10%、校正符合率74.97%。结论醋白上皮持续时间迭6rain,出现宫颈上皮内瘤变几率明显提高,醋酸试验阴道镜病理检查联合应用筛查宫颈病变有显著的临床应用价值;不使用Lugol碘溶液对阴道镜诊断宫颈病变的灵敏度、粗符合率明显提高,漏诊率明显下降,特异度、误诊率均相似。 展开更多
关键词 醋酸试验阴道镜病理检查 宫颈病变 临床应用价值
下载PDF
高低淋巴道转移力小鼠肝癌细胞间抑制性消减杂交文库的建立 被引量:4
4
作者 侯力 唐建武 +3 位作者 崔晓楠 王波 宋波 孙雷 《中华肿瘤防治杂志》 CAS 2006年第1期11-14,共4页
目的:以抑制性消减杂交技术分离高低淋巴道转移力小鼠肝癌细胞HcaF和HcaP间差异表达的基因。方法:采用抑制性消减杂交技术,以高低转移力小鼠肝癌细胞HcaF为检测子,以低转移力HcaP细胞为驱赶子,分离高转移力癌细胞中高表达的基因的cDNA... 目的:以抑制性消减杂交技术分离高低淋巴道转移力小鼠肝癌细胞HcaF和HcaP间差异表达的基因。方法:采用抑制性消减杂交技术,以高低转移力小鼠肝癌细胞HcaF为检测子,以低转移力HcaP细胞为驱赶子,分离高转移力癌细胞中高表达的基因的cDNA片段。将差异表达基因的cDNA片段插入T/A克隆载体,并通过热转化的方法转化大肠埃希菌DH5α,建立了高低淋巴道转移力小鼠肝癌细胞间抑制性消减杂交文库。以菌液PCR的方法检测随机挑选的白色菌落中插入片段的出现频率。提取14个重组质粒进行序列分析。结果:在消减文库中共获800个白色菌落,对随机挑选的160个白色菌落进行菌液PCR扩增,发现95%的白色菌落中含有100~700bp的插入片段。对重组质粒的序列分析和同源性比对发现,所获的14个序列中3个为已知基因,分别来自小鼠热休克蛋白、ribosomalproteinS13、ethanolinduced6基因;4个可能来源于新基因;3个与3个不同的EST同源。结论:成功构建了高低淋巴道转移力小鼠肝癌细胞间抑制性消减杂交文库,为今后高通量筛选癌淋巴道转移相关基因,奠定了坚实的基础。 展开更多
关键词 肝肿瘤 试验性/病理 肿瘤转移 癌基因 杂交
下载PDF
里默氏杆菌与小鹅瘟混合感染番鸭的诊治报告
5
作者 易康梅 欧洪 《农技服务》 2017年第9期143-143,共1页
文章简述通过病理解剖番鸭感染里默氏杆菌后的症状。
关键词 混合感染 病理试验 治疗方法
下载PDF
Point-of-care continuous ^(13)C-methacetin breath test improves decision making in acute liver disease: Results of a pilot clinical trial 被引量:6
6
作者 Gadi Lalazar Tomer Adar Yaron Ilan 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第8期966-972,共7页
AIM: To assess the role of the 13C-methacetin breath test (MBT) in patients with acute liver disease. METHODS: Fifteen patients with severe acute liver disease from diverse etiologies were followed-up with 13C-MBT dur... AIM: To assess the role of the 13C-methacetin breath test (MBT) in patients with acute liver disease. METHODS: Fifteen patients with severe acute liver disease from diverse etiologies were followed-up with 13C-MBT during the acute phase of their illnesses (range 3-116 d after treatment). Patients fasted for 8 h and ingested 75 mg of methacetin prior to the MBT. We compared results from standard clinical assessment, serum liver enzymes, synthetic function, and breath test scores. RESULTS: Thirteen patients recovered and two patients died. In patients that recovered, MBT parameters improved in parallel with improvements in lab results. Evidence of consistent improvement began on day 3 for MBT parameters and between days 7 and 9 for blood tests. Later convergence to normality occurred at an average of 9 d for MBT parameters and from 13 to 28 d for blood tests. In both patients that died, MBT parameters remained low despite fluctuating laboratory values. CONCLUSION: The 13C-MBT provides a rapid, noninvasive assessment of liver function in acute severe liver disease of diverse etiologies. The results of this pilot clinical trial suggest that the MBT may offer greater sensitivity than standard clinical tests for managing patients with severe acute liver disease. 展开更多
关键词 Acute liver disease Methacetin Breath test Fulminant hepatitis
下载PDF
No evidence demonstrating hepatotoxicity associated with hydroxycitric acid 被引量:2
7
作者 Sidney J Stohs Harry G Preuss +4 位作者 Sunny E Ohia Gilbert R Kaats Carl L Keen Lonnie D Williams George A Burdock 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第32期4087-4089,共3页
Although a number of cases of hepatotoxicity are associated with the use of Hydroxycut weight management products, it has been alleged that their effects are primarily due to the presence of hydroxycitric acid (HCA, a... Although a number of cases of hepatotoxicity are associated with the use of Hydroxycut weight management products, it has been alleged that their effects are primarily due to the presence of hydroxycitric acid (HCA, as Super CitriMax) in the formulations. However, while these products contain up to 20 different ingredients, some do not contain HCA. Case studies reported to date have not considered in depth the literature on the numerous animal and human studies that have been conducted on the safety and effi cacy of HCA. No HCA-associated hepatotoxicity or treatment-related adverse effects have been reported in these studies, and thus it is premature to make the assumptions presented in the recent case studies regarding Hydroxycut. If it is established in well controlled studies that the use of these formulations with and/or without HCA can result in the occurrence or progression of hepatotoxicity, additional studies should be conducted to characterize the causative factor(s). 展开更多
关键词 Hydroxycitric acid Super CitriMax Hydroxycitric acid-SX Garcinia cambogia Hydroxycut Liver failure HEPATOTOXICITY Safety and efficacy
下载PDF
Grey Disorder in Field Flue-Cured Tobacco
8
作者 ZHANG XIN ZHAO QIBO +1 位作者 YU HUIMEI CAO ZHIHONG(1Institute of Soil Science, the Chinese Academy of Sciences, Nanjing 210008 (China))(2Jiangsu Provincial Tobacco Company, Nanjing 210O29 (China)) 《Pedosphere》 SCIE CAS CSCD 1999年第4期369-374,共6页
A field study was carried out on the grey disorder in fine-cured tobacco (Nicotiana tabacum L.) leaves.The results showed that low Eh and high available Fe content in the soils were responsible for the grey tobaccoand... A field study was carried out on the grey disorder in fine-cured tobacco (Nicotiana tabacum L.) leaves.The results showed that low Eh and high available Fe content in the soils were responsible for the grey tobaccoand dead roots. Grey disorder leaves produced low quality lamina, which was low in N, nicotine, reducedsugar and K contents. In this study’ soil available Mn and leaf Mn contents were in a relatively low level andshould not be an important factor in the occurrence of grey disorder in fine-cured tobacco. 展开更多
关键词 flue-cured tobacco grey disorder IRON MANGANESE TOXICITY
下载PDF
Role of conventional therapies in the era of biological treatment in Crohn’s disease
9
作者 Paolo Gionchetti Carlo Calabrese +7 位作者 Rosy Tambasco Ramona Brugnera Giulia Straforini Giuseppina Liguori Giulia Spuri Fornarini Donatella Riso Massimo Campieri Fernando Rizzello 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第14期1797-1806,共10页
Outstanding progress regarding the pathophysiology of Crohn's disease (CD) has led to the development of innovative therapeutic concepts. Numerous controlled trials have been performed in CD. This review concentra... Outstanding progress regarding the pathophysiology of Crohn's disease (CD) has led to the development of innovative therapeutic concepts. Numerous controlled trials have been performed in CD. This review concentrates on the results of randomized,placebo-controlled trials,and meta-analyses when available,that provide the highest degree of evidence. Current guidelines on the management of CD recommend a step-up approach to treatment involving the addition of more powerful therapies as the severity of disease and refractoriness to therapy increase. The advent of biological drugs has opened new therapeutic horizons for treating CD,modifying the treatment goals. However,the large majority of patients with CD will be managed through conventional therapy,even if they are a prelude to biological therapy. 展开更多
关键词 Crohn’s disease SULFASALAZINE 5-Aminosalicylic acid AZATHIOPRINE 6-MERCAPTOPURINE Biological therapies Anti-tumor necrosis facto-α
下载PDF
Scrub typhus hepatitis confirmed by immunohistochemical staining 被引量:3
10
作者 Jong-Hoon Chung Sung-Chul Lim +3 位作者 Na-Ra Yun Sung-Heui Shin Choon-Mee Kim Dong-Min Kim 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第36期5138-5141,共4页
Scrub typhus is an acute febrile disease caused by Orientia tsutsugamushi (0. tsutsugamushi). We report herein the case of a woman who presented with fever and elevated serum levels of liver enzymes and who was defi... Scrub typhus is an acute febrile disease caused by Orientia tsutsugamushi (0. tsutsugamushi). We report herein the case of a woman who presented with fever and elevated serum levels of liver enzymes and who was definitively diagnosed with scrub typhus by his- topathological examination of liver biopsy specimens, serological tests and nested polymerase chain reaction. Immunohistochemical staining using a monoclonal an- ti-O. tsutsugamushi antibody showed focally scattered positive immunoreactions in the cytoplasm of some hepatocytes. This case suggests that scrub typhus hepatitis causes mild focal inflammation due to direct liver damage without causing piecemeal necrosis or interface hepatitis. Thus, scrub typhus hepatitis differs from acute viral hepatitis secondary to liver damage due to host immune responses, which causes severe Iobular disarray with diffuse hepatocytic degeneration, necrosis and apoptosis as well as findings indicative of hepatic cholestasis, such as hepatic bile plugs or brown pigmentation of hepatocytes. 展开更多
关键词 Scrub typhus Immunohistochemistry Ori-entia tsutsugamushi
下载PDF
Expression of HIF-1α in hepatocellular carcinoma and its relationship with vasculogenic mimicry and clinical pathology
11
作者 Xiaojie Ma Jie Li Bangxian Tan 《The Chinese-German Journal of Clinical Oncology》 CAS 2013年第11期528-531,共4页
Objective: The aim of this study was to discuss HIF-la expression and vasculogenic mimicry (VM) in hepatocel- lular carcinoma (HCC) and their relationship with the clinical pathological features and clinical sign... Objective: The aim of this study was to discuss HIF-la expression and vasculogenic mimicry (VM) in hepatocel- lular carcinoma (HCC) and their relationship with the clinical pathological features and clinical significance. Methods: Two hundred and seven specimens from patients in The Affiliated Hospital of North Sichuan Medical College who received hepatic cell carcinoma resection were tested by immunohistochemistry and double staining of CD31 and PSA. Then detected the expression of HIF-la, VM, and analysed the relationship between clinical pathology. Results: The HIF-la positive rate was 71.01% and its expression was associated with liver cirrhosis, tumor size and TNM stage (P 〈 0.05). HIF-la protein expres- sion was positively associated with the VM (y = 0.1988, P = 0.0041). Conclusion: Hypoxia may be the reason for VM in high invasive HCC, regulating the tumor microenvironment may have great significance in inhibiting invasion and metastasis of HCC. 展开更多
关键词 hepatocellular carcinoma (HCC) HIF-la vasculogenic mimicry (VM)
下载PDF
Non-Specific Factors Involved in the Treatment: Its Influence on Treatment Adherence
12
作者 Gerardo A. Fridman 《Journal of Pharmacy and Pharmacology》 2017年第6期340-348,共9页
Introduction: The effectiveness of treatment depends on the efficacy of the therapy and the level of compliance of the patient. NF (non-specific factors) involved in treatment are all those effects that do not depe... Introduction: The effectiveness of treatment depends on the efficacy of the therapy and the level of compliance of the patient. NF (non-specific factors) involved in treatment are all those effects that do not depend on the pharmacological properties of the drug. Materials and Methods: The job lasted a year. The sample consisted of patients with mental health disorders and was divided into two groups. Treatment compliance was measured with the Morisky-Green Test. Results were compared using the chi square test and relative risk. Results and Discussion: Group A had 23 patients ending 91.3% of them and group B of 22 patients, ending the 77.27%. At the beginning of the study, we found in the group A 0.86 NF/patients while in the group B 0.82 NF/patient. At the end of the study there was a 54.65% decrease in group A while in group B the proportion remained. At the beginning of the study both groups had approximately 40% of compliant patients. Data that remained in the control group rose to 80.95% in group A at the end of the study. Conclusions: The work demonstrates the negative influence of these factors on adherence to treatment. 展开更多
关键词 Adhesion to treatment nonspecific factors influencing treatment health professional patient family environment.
下载PDF
毒性病理同行评议要求 被引量:4
13
作者 孔庆喜 姚全胜 +4 位作者 黄奕奕 李荣荣 李曼 吕娟 杨然 《药物评价研究》 CAS 2011年第5期370-373,共4页
毒性病理同行评议(peer review)的目的是核实病理诊断和病理解释的正确性,提高病理报告的质量,执行的时机通常在试验总报告完成前。负责同行评议的病理学家将复查足够的切片和病理数据,帮助试验病理学家进一步确认、精炼病理诊断和数据... 毒性病理同行评议(peer review)的目的是核实病理诊断和病理解释的正确性,提高病理报告的质量,执行的时机通常在试验总报告完成前。负责同行评议的病理学家将复查足够的切片和病理数据,帮助试验病理学家进一步确认、精炼病理诊断和数据解释。同行评议需筛选复查的材料由试验病理学家提供,必要时,可临时成立病理专家小组来解决争议或分歧。试验病理学家根据同行评议讨论产生的结果对病理数据和病理报告进行相应修改,并签署最终病理报告,是唯一对试验最终病理数据和病理报告内容负责的人。同行评议病理学家需出具签名的同行评议报告,报告中描述同行评议的程序,确认试验病理学家的病理报告是正确、恰如其分地反应病理数据。试验的病理学家也需要在同行评议报告上签名,以表明同意同行评议病理学家的观点。总结了毒性病理同行评议当前执行的类型和模式推荐,可根据特定试验需要而进行改变。 展开更多
关键词 毒性病理 同行评议 试验病理 病理诊断
原文传递
Hepatic encephalopathy 被引量:6
14
作者 Peter Ferenci 《Gastroenterology Report》 SCIE EI 2017年第2期138-147,I0002,共11页
Hepatic encephalopathy(HE)is a reversible syndrome of impaired brain function occurring in patients with advanced liver diseases.The precise pathophysiology of HE is still under discussion;the leading hypothesis focus... Hepatic encephalopathy(HE)is a reversible syndrome of impaired brain function occurring in patients with advanced liver diseases.The precise pathophysiology of HE is still under discussion;the leading hypothesis focus on the role of neurotoxins,impaired neurotransmission due to metabolic changes in liver failure,changes in brain energy metabolism,systemic inflammatory response and alterations of the blood brain barrier.HE produces a wide spectrum of nonspecific neurological and psychiatric manifestations.Minimal HE is diagnosed by abnormal psychometric tests.Clinically overt HE includes personality changes,alterations in consciousness progressive disorientation in time and space,somnolence,stupor and,finally,coma.Except for clinical studies,no specific tests are required for diagnosis.HE is classified according to the underlying disease,the severity of manifestations,its time course and the existence of precipitating factors.Treatment of overt HE includes supportive therapies,treatment of precipitating factors,lactulose and/or rifaximin.Routine treatment for minimal HE is only recommended for selected patients. 展开更多
关键词 Hepatic encephalopathy PATHOPHYSIOLOGY diagnostic tests management strategy
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部